Deletion beta thalassemia detection primers and beta thalassemia detection kit based on SNP analysis and application of deletion beta thalassemia detection kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GUANGDONG WOMEN & CHILDREN HOSPITAL
- Publication Date
- 2019-12-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a detection primer, kit and application of deletion-type β-thalassemia based on SNP analysis. Background technique
[0002] Thalassemia is one of the most common monogenic genetic diseases. Common types of thalassemia include α-thalassemia and β-thalassemia, which are caused by abnormal expression of α-globin gene cluster and β-globin gene cluster, respectively. It is mainly distributed in Southeast Asia. It is estimated that about 1.5% of the world's population (800,000 to 90,000,000 people) are carriers of thalassemia, and at least 60,000 newborns are seriously affected every year, accounting for the vast majority in developing countries. In my country, the area south of the Yangtze River is a high-incidence area of thalassemia, mainly in Guangxi, Guangdong, and Hainan. At present, there is no effective treatment for this disease. Children with severe...